O-Cal Kit Tablet combines Ibandronic Acid 150 mg and Calcium Orotate 740 mg, offering a comprehensive approach to bone health and osteoporosis management. This dual-action tablet is designed for adults, particularly postmenopausal women and elderly individuals, who are at risk of bone loss, fractures, or calcium deficiency. By combining a bisphosphonate with a bioavailable calcium source, O-Cal Kit not only slows down bone resorption but also supports bone mineralization and overall skeletal strength.

• Ibandronic Acid is a potent bisphosphonate that inhibits osteoclast activity, reducing bone breakdown and increasing bone density.

• Calcium Orotate provides elemental calcium in a highly absorbable form, ensuring proper bone mineralization and supporting musculoskeletal function.

Together, these ingredients provide an integrated solution for maintaining bone integrity and reducing fracture risk.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Key Benefits

• Prevents and treats osteoporosis in postmenopausal women and adults at risk

• Reduces the risk of vertebral fractures and bone loss

• Supports bone mineralization and skeletal strength

• Provides highly absorbable calcium for optimal bioavailability

• Enhances musculoskeletal health, including muscle and nerve function

• Promotes overall metabolic and bone wellness

Mechanism of Action

1. Ibandronic Acid (150 mg):

   • Inhibits the activity of osteoclasts, the cells responsible for bone resorption.

   • Slows bone loss and maintains bone density.

   • Reduces the risk of fractures in osteoporotic patients.

2. Calcium Orotate (740 mg):

   • Supplies elemental calcium to strengthen bones and teeth.

   • Orotic acid enhances cellular calcium uptake, improving bioavailability.

   • Supports bone mineralization and overall skeletal health.

3. Synergistic Effect:
   The combination of a bisphosphonate and calcium ensures both the preservation of existing bone and the supply of essential minerals for new bone formation, providing a complete approach to bone health.

Indications

O-Cal Kit Tablet 150 mg & 740 mg is indicated for:

• Prevention and treatment of postmenopausal osteoporosis

• Adults at high risk of osteoporotic fractures

• Patients with calcium deficiency requiring supplementation

• Supportive therapy for maintaining bone density in elderly individuals

• General skeletal health maintenance in adults with increased calcium and bone requirements

Dosage and Administration

• Recommended dose: One tablet once daily, or as directed by a healthcare professional.

• Take the tablet with a full glass of water on an empty stomach, at least 60 minutes before the first food, drink, or other medications of the day.

• Swallow the tablet whole; do not crush, chew, or suck.

• Remain upright for at least 30–60 minutes after ingestion to reduce the risk of esophageal irritation.

• Ensure adequate intake of vitamin D and water to maximize calcium absorption and bone health benefits.

Precautions and Warnings

• Consult a physician before use if you have kidney disease, esophageal disorders, hypocalcemia, or other chronic conditions.

• Not recommended during pregnancy or breastfeeding unless prescribed.

• Avoid lying down immediately after taking the tablet to prevent esophageal irritation.

• Maintain adequate hydration while on therapy.

• Use caution in patients taking other calcium or mineral supplements.

  রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Possible Side Effects

Common side effects may include:

• Mild gastrointestinal discomfort or heartburn

• Muscle or joint pain

• Nausea

• Rarely, esophageal irritation

Seek medical attention if severe or persistent side effects occur.

Storage

Store below 30°C in a dry, cool place, protected from light and moisture. Keep out of reach of children.

O-Cal Kit Tablet 150 mg & 740 mg provides a comprehensive solution for bone health, combining the anti-resorptive effects of Ibandronic Acid with the nutritional support of Calcium Orotate to maintain skeletal strength, prevent osteoporosis, and reduce fracture risk.